Novomix Flexpen 30

Novomix Flexpen 30

Description:

Novomix Flexpen 30 (NOVOMIX 30 100 i.u./ml 5 Flexpen) is a prescription premixed insulin analog used for the treatment and control of diabetes mellitus. It contains a combination of rapid-acting and intermediate-acting insulin aspart formulations to help control blood glucose levels before and after meals and throughout the day. Supplied in a prefilled, disposable Flexpen, it is designed for convenient and accurate subcutaneous insulin delivery as part of a comprehensive diabetes care plan, including diet, exercise, and regular blood glucose monitoring.

Indications:

• Management of diabetes mellitus in adults, adolescents, and children who require insulin for blood glucose control.
• Type 1 diabetes mellitus: as part of a basal–bolus or premixed insulin regimen to control fasting and postprandial blood glucose.
• Type 2 diabetes mellitus: when oral antidiabetic medicines alone are insufficient to achieve adequate glycemic control.
• Helps reduce symptoms of hyperglycemia such as excessive thirst, frequent urination, fatigue, and blurred vision when used as prescribed.

Active Ingredients / Key Components:

• Insulin aspart (soluble, rapid-acting insulin analog) – part of the 100 i.u./ml premix (exact units of each component per ml are not specified in the provided data).
• Insulin aspart protamine (intermediate-acting insulin aspart–protamine complex) – part of the 100 i.u./ml premix (exact units of each component per ml are not specified in the provided data).
• Concentration: 100 i.u./ml.
• Each Flexpen: 5 prefilled pens (exact insulin amount per pen in units or ml is not specified in the provided data).
• Other excipients: detailed excipient list is not available in the provided information; please refer to the official package leaflet for full composition.

Dosage & Administration / How to Use:

• Dosage is individualized by the treating physician based on blood glucose measurements, type of diabetes, body weight, diet, physical activity, and concomitant medications.
• Novomix Flexpen 30 is usually administered subcutaneously shortly before a meal. Your doctor may advise injecting immediately before the meal or, in some cases, just after starting the meal.
• Typical total daily insulin dose for many patients ranges around 0.5–1.0 units/kg/day (exact dose must be determined by the healthcare provider; this product’s specific starting dose regimen is not provided in the available data).
• Injection sites: abdomen, thigh, upper arm, or buttock. Rotate injection sites within the same region to reduce the risk of lipodystrophy or skin thickening.
• Do not inject intravenously or intramuscularly. Do not use in insulin infusion pumps.
• Using the Flexpen:
  • Check the label to confirm the correct insulin.
  • Inspect the insulin: Novomix 30 is a cloudy suspension; gently roll the pen between the palms and invert it several times until the suspension appears uniformly milky. Do not use if clumps or particles remain or if the suspension does not mix evenly.
  • Attach a new sterile needle before each injection.
  • Perform an air shot (priming) according to the manufacturer’s instructions to ensure proper insulin flow.
  • Dial the prescribed dose in units using the dose selector.
  • Inject subcutaneously as instructed by your healthcare professional and keep the needle under the skin for several seconds (as per leaflet instructions) to ensure full dose delivery.
  • Remove and safely discard the needle after each injection. Do not share pens or needles with others.
• Use with or without food: Novomix Flexpen 30 must be used in relation to meals (usually just before eating); do not skip meals after injecting.
• Missed dose: If you miss a dose, follow your doctor’s advice. Do not double the next dose to make up for a missed one. Monitor blood glucose and seek medical advice if levels are very high or you are unsure what to do.

Clinical Benefits:

• Provides both rapid and intermediate insulin action in a single injection, helping to control post-meal spikes and between-meal/overnight blood glucose levels.
• Supports improved glycemic control in patients with type 1 and type 2 diabetes when used as part of an individualized treatment plan.
• Helps reduce the risk of long-term diabetes complications associated with poor glycemic control, such as neuropathy, nephropathy, and retinopathy, when target glucose levels are maintained.
• Convenient prefilled Flexpen device allows accurate dosing, easy handling, and portable use, supporting adherence to insulin therapy.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to insulin aspart, insulin aspart protamine, or any of the excipients.
• Do not use during episodes of hypoglycemia (low blood sugar). Blood glucose must be corrected before administering insulin.
• Use with caution in patients with renal or hepatic impairment; insulin requirements may be reduced and close monitoring is required.
• Changes in insulin type, strength, manufacturer, or regimen must be done only under medical supervision, as dose adjustments may be necessary.
• Alcohol, certain medications (such as beta-blockers, corticosteroids, oral antidiabetics, ACE inhibitors, diuretics, and others), and acute illness can affect insulin requirements and blood glucose levels. Inform your doctor about all medicines you are taking.
• Pregnancy and breastfeeding: Consult your doctor before use. Insulin requirements may change during pregnancy and after delivery; close medical supervision and frequent blood glucose monitoring are essential.
• Driving and operating machinery: Hypoglycemia can impair concentration and reaction time. Take precautions to avoid low blood sugar while driving or using machines.
• Never share your Flexpen or needles with anyone else, even if the needle is changed, to prevent cross-infection.
• Not intended to diagnose, treat, cure, or prevent any disease outside its approved indication for diabetes mellitus.
• Keep out of reach of children.

Side Effects:

• Common side effects: Hypoglycemia (low blood sugar) is the most frequent adverse effect. Symptoms may include sweating, tremor, palpitations, hunger, headache, dizziness, confusion, blurred vision, and weakness.
• Local reactions at the injection site: Redness, swelling, itching, pain, or bruising may occur and usually resolve with continued use. Lipodystrophy or skin thickening may occur if injection sites are not rotated.
• Allergic reactions: Rash, itching, or swelling at the injection site; rarely, generalized allergic reactions may occur. Seek urgent medical attention if you experience difficulty breathing, swelling of the face or throat, or severe rash.
• Edema (fluid retention) and temporary visual disturbances may occur when starting insulin therapy or when glycemic control improves rapidly.
• Seek immediate medical attention if you experience severe or recurrent hypoglycemia, signs of severe allergic reaction, or if blood glucose remains very high despite using insulin as directed.

Storage Instructions:

Store unopened Flexpens in a refrigerator at 2–8 °c. Do not freeze and do not place near the freezer compartment or cooling element. Protect from direct heat and light. Once in use, the Flexpen may generally be kept at room temperature (exact in-use storage conditions and duration are not specified in the provided data; refer to the official leaflet for precise instructions). Keep the cap on the pen when not in use. Do not use after the expiry date printed on the pack. Keep out of reach of children.

Specifications:

• Product type: Prescription insulin medicine for diabetes care.
• Active ingredients: Insulin aspart + insulin aspart protamine, concentration 100 i.u./ml (exact ratio between components is not provided in the available data).
• Form: Prefilled, disposable Flexpen for subcutaneous injection.
• Pack size: 5 Flexpens (exact volume or units per pen are not specified in the provided data).
• Intended users: Adults, adolescents, and children with diabetes mellitus, as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.